INVI yields 2000000.00% · JNJ yields 2.13%● Live data
📍 INVI pulled ahead of the other in Year 1
Combined, INVI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INVI + JNJ for your $10,000?
Integral Vision, Inc. develops, manufactures, and markets flat panel display inspection systems for the display manufacturing processes. It primarily inspects micro displays and small flat panel displays. The company's products evaluate operating displays for cosmetic and functional defects, as well as provide electrical testing. Its products include SharpEye systems that provide flat panel display inspection for reflective, emissive, and transmissive display technologies; and detects functional and cosmetic defects in liquid crystal display (LCD) displays, as well as liquid crystal on silicon, OLED, microelectromechanical systems, 3LCD/high temperature poly-silicon, e-paper, and other display technologies. The company's technologies are applied to various consumer products, including a range of hand held devices, e-books, computer monitors, digital still cameras, HDTV, projectors, and video headsets. It sells its products directly in the United States, as well as through sales representatives in Asia and Europe. Integral Vision, Inc. was founded in 1978 and is headquartered in Wixom, Michigan.
Full INVI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.